ELOXATINE 5 mg/ml, solution à diluer pour perfusion, ELOXATINE 5 mg/ml, solution à diluer pour perfusion
PRODIGE 49 -OSCAR
Phase 3 small_molecule active
Quick answer
ELOXATINE 5 mg/ml, solution à diluer pour perfusion, ELOXATINE 5 mg/ml, solution à diluer pour perfusion for colon cancer and rectal with liver metastasis is a Phase 3 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- colon cancer and rectal with liver metastasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active